【摘要】 背景与目的 继表皮生长因子（epidermal growth factor receptor, EGFR）突变之后，间变性淋巴瘤激酶 （anaplastic lymphoma kinase, ALK）基因重排的非小细胞肺癌（non-small cell lung cancer, NSCLC）已经成为了肺癌的又 The overall concordance between V-IHC and FISH is 91.7% (11/12). Conclusion The V-IHC method is a reliable method for ALK arrangement and could be used in clinical screen and diagnosis.
and accurately. So the objective of our research is to detect ALK rearrangement in 172 cases of NSCLC by using enhancing immunohistochemical way (ventana-IHC, V-IHC). Methods ALK rearrangement in 172 NSCLC samples was detected by using V-IHC, and positive staining cases were further verified by fluorescence in situ hybridization (FISH). Results Among 172 NSCLC cases, there were 12 positive staining. The positive results were confirmed by FISH and 11 cases were FISH positive.
The overall concordance between V-IHC and FISH is 91.7% (11/12 
